RAB3D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.105600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.359600E-01
Normal-vs-Stage2
2.206200E-01
Normal-vs-Stage3
3.236400E-01
Normal-vs-Stage4
3.288200E-01
Stage1-vs-Stage2
8.425200E-01
Stage1-vs-Stage3
8.339200E-01
Stage1-vs-Stage4
9.033600E-01
Stage2-vs-Stage3
7.060600E-01
Stage2-vs-Stage4
9.849400E-01
Stage3-vs-Stage4
7.907600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.143000E-01
Normal-vs-AfricanAmerican
1.075430E-01
Normal-vs-Asian
2.310600E-01
Caucasian-vs-AfricanAmerican
9.299000E-01
Caucasian-vs-Asian
5.903800E-01
AfricanAmerican-vs-Asian
5.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.415000E-01
Normal-vs-Female
1.644440E-01
Male-vs-Female
4.121600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.430400E-01
Normal-vs-Age(41-60Yrs)
2.066400E-01
Normal-vs-Age(61-80Yrs)
2.362000E-01
Normal-vs-Age(81-100Yrs)
1.287190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.536600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.030400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.566600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.951200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.814400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.731200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.442590E-01
Normal-vs-Daily Drinker
2.363400E-01
Normal-vs-Weekly Drinker
3.415800E-01
Normal-vs-Occasional Drinker
9.003700E-02
Normal-vs-Social Drinker
1.645960E-01
Non Drinker-vs-Daily Drinker
9.939000E-01
Non Drinker-vs-Weekly Drinker
1.365380E-01
Non Drinker-vs-Occasional Drinker
8.312000E-01
Non Drinker-vs-Social Drinker
4.212800E-01
Daily Drinker-vs-Weekly Drinker
2.208600E-01
Daily Drinker-vs-Occasional Drinker
8.538800E-01
Daily Drinker-vs-Social Drinker
4.962600E-01
Weekly Drinker-vs-Occasional Drinker
8.666300E-02
Weekly Drinker-vs-Social Drinker
7.546100E-02
Occasional Drinker-vs-Social Drinker
5.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.154400E-01
Normal-vs-Grade 2
1.235760E-01
Normal-vs-Grade 3
4.351600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.815640E-01
Grade 1-vs-Grade 3
3.073200E-01
Grade 1-vs-Grade 4
2.154400E-01
Grade 2-vs-Grade 3
5.486000E-01
Grade 2-vs-Grade 4
1.235760E-01
Grade 3-vs-Grade 4
4.351600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.021600E-01
Normal-vs-NonDiabetic
1.703000E-01
Diabetic-vs-NonDiabetic
4.423400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.829900E-02
Normal-vs-NoPancreatitis
1.941980E-01
Pancreatitis-vs-NoPancreatitis
6.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.609400E-01
Normal-vs-N1
2.057000E-01
N0-vs-N1
7.322200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.410300E-02
Normal-vs-TP53-NonMutant
1.490240E-01
TP53-Mutant-vs-TP53-NonMutant
7.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
